发明名称 Triazole derivatives for treatment of Alzheimer's disease
摘要 According to the invention there is provided a compound of formula I or a pharmaceutically acceptable salt or hydrate thereof; wherein the variables are as defined herein. The compounds selectively attenuate the production of Abeta42 and hence are useful in treatment of Alzheimer's disease and related conditions.
申请公布号 US8575150(B2) 申请公布日期 2013.11.05
申请号 US200913139830 申请日期 2009.12.07
申请人 FISCHER CHRISTIAN;METHOT JOEY;ZHOU HUA;SCHELL ADAM J.;MUNOZ BENITO;RIVKIN ALEXEY A.;AHEARN SEAN P.;CHICHETTI STEPHANIE;MACCOSS RACHEL N.;KATTAR SAM;CHRISTOPHER MATTHEW;LI CHAOMIN;ROSENAU ANDREW;BROWN WILLIAM COLBY;MERCK SHARP & DOHME CORP. 发明人 FISCHER CHRISTIAN;METHOT JOEY;ZHOU HUA;SCHELL ADAM J.;MUNOZ BENITO;RIVKIN ALEXEY A.;AHEARN SEAN P.;CHICHETTI STEPHANIE;MACCOSS RACHEL N.;KATTAR SAM;CHRISTOPHER MATTHEW;LI CHAOMIN;ROSENAU ANDREW;BROWN WILLIAM COLBY
分类号 C07D249/14;A61K31/4196 主分类号 C07D249/14
代理机构 代理人
主权项
地址